NexImmune (NEXI) Net earnings per share growth forecast for next year

Symbol and logo of brand NexImmune Corp (NEXI)

NexImmune, Inc. (NEXI) is implementing robotic systems to scale oncology drugs, reducing manual labor. Management is currently finalizing the liquidation of the structure following the cessation of all development. This 12-month EPS growth chart visualizes the analysts' consensus forecast, where the value 0.00 represents the current figure. However, geopolitical conflicts and sanctions are disrupting biomaterial logistics, hindering the creation of new immunotherapy agents.

NEXI - NexImmune Corp Earnings growth forecast for next year over the range 07/04/2022 - 08/04/2024

Metric breakdowns and analytics for NexImmune Corp (NEXI)

- price and consensus price forecast:
Price Chart neximmune.com|NEXI - Consensus Target
- market capitalization details:
Market Value NexImmune Corp|NEXI - Real Price to Acquire Entire Company
- company book value details:
Accounting Value per Share NexImmune|NEXI - Book Capitalization|Market Value to Book Value Ratio neximmune.com|NEXI - Total Business Assets
- company liabilities and liquidity data:
Debt to Equity NexImmune, Inc.|NEXI - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio NexImmune Inc|NEXI - Company Total Indebtedness|Debt to Book Value NexImmune|NEXI - Amount of Long-Term Liabilities|Company Short-Term Debts NexImmune|Quick Ratio neximmune.com
- earnings and market ratios statistics:
NEXI - Company Net Income|Expected Profit NexImmune, Inc.|NEXI - Company Value to Net Income|Forward P/E Multiple neximmune.com|NEXI - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NexImmune, Inc.|NEXI - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months NexImmune|NEXI - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months neximmune.com|NEXI - Earnings per share growth this year|Earnings growth forecast for next year NexImmune, Inc.
- revenue and sales proceeds data:
NEXI - Company Total Revenue|Company Future Sales Volume NexImmune|NEXI - Market Cap to Revenue Ratio|Forward P/S Multiple NexImmune Corporation|NEXI - Annual Revenue Growth (Last Twelve Months)
Analysis of all company metrics:NexImmune Corp
Core merchandise of NexImmune Inc

Investors must balance expected returns on capital against the risks of pharmaceutical supply chain disruptions and the complexities of global patent protection for NexImmune, Inc. (NEXI). The modeled EPS growth for the next fiscal year is calculated via the order book microstructure, measuring the consensus earnings forecast to assess the fundamental resilience of the business amid shifting economic cycles.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen Ltd.)|Expected earnings per share trend next year IOBT|sutrobio.com - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics, Inc|Werewolf (HOWL) - Net earnings per share growth forecast for next year|Immix Biopharma Inc. - Expected earnings per share trend next year|ALXO (alxoncology.com) - Earnings growth forecast for next year|Cue Biopharma, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year pdsbiotech.com (PDSB)|SONN: Net earnings per share change forecast for next year|MAIA Biotech - Expected earnings per share growth for next year|liminatuspharma.com (LIMN) - Expected net earnings per share growth next year|LVTX - Net earnings per share growth forecast for next year|NXTC (NextCure) - Projected earnings per share growth rate for next year|LPTX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year INTS|Net earnings per share growth forecast for next year Sensei Biotherapeutics, Inc.|Expected net earnings per share growth next year therivabio.com TOVX|Expected earnings per share growth for next year GRTS (Gritstone bio, Inc.)|Earnings growth forecast for next year Kineta Bio (KA)|Net earnings per share growth forecast for next year turnstonebio.com TSBX|Consensus forecast of earnings per share growth for next year Vaccinex Inc (VCNX)|HARP - Net earnings per share growth forecast for next year